AstraZeneca scores another industry victory over the federal government in 340B litigation

The US district court of Delaware handed AstraZeneca a victory late Wednesday, effectively setting aside a violation letter sent by President Biden’s Health Resources and Services Administration for the company’s failure to comply with its obligations under a federal program providing low-income individuals with less expensive drugs.